Status:
RECRUITING
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
University of Nebraska
University of Utah
Conditions:
Uveitis
Infectious Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multi-center randomized controlled evaluator-masked trial designed to compare metagenomic deep sequencing (MDS) versus standard of care testing for improvement of outcomes for intraocular in...
Eligibility Criteria
Inclusion
- Presumed infectious anterior uveitis, or intermediate uveitis, or posterior uveitis, or panuveitis
- Presumed post-operative endophthalmitis
- Unilateral or bilateral
- 18 years and older
Exclusion
- Insufficient specimen for MDS
- Age \< 18 years of age
- Pregnancy
- Unable to consent
Key Trial Info
Start Date :
June 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05286203
Start Date
June 6 2022
End Date
December 1 2026
Last Update
July 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco (UCSF)
San Francisco, California, United States, 94158